New drug combo shows promise for Hard-to-Treat cancers

NCT ID NCT07414836

First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 7 times

Summary

This early-phase study tests a new drug called BG-C0979, alone or with another drug (tislelizumab), in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the right dose, and see if the drug shrinks tumors. About 84 adults with various advanced cancers will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Cabrini Hospital Malvern

    RECRUITING

    Malvern, Victoria, VIC 3144, Australia

  • Cancer Hospital Chinese Academy of Medical Sciences

    RECRUITING

    Beijing, Beijing Municipality, 100021, China

  • Fudan University Shanghai Cancer Centerpudong

    RECRUITING

    Shanghai, Shanghai Municipality, 201321, China

  • Hospital Clinic de Barcelona

    RECRUITING

    Barcelona, 08036, Spain

  • Hospital Universitario Fundacion Jimenez Diaz

    RECRUITING

    Madrid, 28040, Spain

  • Hospital Universitario Vall Dhebron

    RECRUITING

    Barcelona, 08035, Spain

  • Icon Cancer Centre South Brisbane

    RECRUITING

    South Brisbane, Queensland, QLD 4101, Australia

  • John Theurer Cancer Center Hackensack University Medical Center

    RECRUITING

    Hackensack, New Jersey, 07601, United States

  • Liverpool Hospital

    RECRUITING

    Liverpool, New South Wales, NSW 2170, Australia

  • Mengchao Hepatobiliary Hospital of Fujian Medical University

    RECRUITING

    Fuzhou, Fujian, 350028, China

  • Next Oncology Madrid

    RECRUITING

    Madrid, 28223, Spain

  • Next Oncology San Antonio

    RECRUITING

    San Antonio, Texas, 78229, United States

  • Northern Beaches Hospital

    RECRUITING

    Frenchs Forest, New South Wales, NSW 2086, Australia

  • Second Affiliated Hospital of Army Medical University (Xinqiao Hospital)

    RECRUITING

    Chongqing, Chongqing Municipality, 400037, China

  • Sun Yat Sen Memorial Hospital, Sun Yat Sen University (South)

    RECRUITING

    Guangzhou, Guangdong, 510245, China

  • Washington University School of Medicine

    RECRUITING

    St Louis, Missouri, 63110-1010, United States

  • Yichang Central Peoples Hospital

    RECRUITING

    Yichang, Hubei, 443003, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.